Novo Nordisk discontinued its development program, and the compound entered the gray-market peptide space without the large-scale efficacy and safety data that regulatory approval requires
The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs
Retatrutide is a high-quality research peptide that is attracting worldwide attention due to its innovative triple action on the GLP-1 , GIP and glucagon receptors
Pure glutathione degrades quickly in standard cream formulas, so Medicube AGE-R encapsulates it inside phospholipid capsules that mimic the skin's own cellular structure
Kidney Problems: GLP-1 medications can sometimes affect kidney function, especially in people with pre-existing kidney disease
However, these medications remain out of reach for many who may benefit the most, prompting important conversations about affordability and equity